These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22908062)

  • 41. Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas.
    Mezzomo LC; Gonzales PH; Pesce FG; Kretzmann Filho N; Ferreira NP; Oliveira MC; Kohek MB
    Pituitary; 2012 Sep; 15(3):420-7. PubMed ID: 21850407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
    Morris DG; Musat M; Czirják S; Hanzély Z; Lillington DM; Korbonits M; Grossman AB
    Eur J Endocrinol; 2005 Jul; 153(1):143-51. PubMed ID: 15994756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
    Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
    Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxisome proliferator-activated receptor (PPAR)gamma is highly expressed in normal human pituitary gland.
    Bogazzi F; Russo D; Locci MT; Chifenti B; Ultimieri F; Raggi F; Viacava P; Cecchetti D; Cosci C; Sardella C; Acerbi G; Gasperi M; Martino E
    J Endocrinol Invest; 2005 Nov; 28(10):899-904. PubMed ID: 16419492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.
    Zatelli MC; Piccin D; Tagliati F; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Culler MD; degli Uberti EC
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2797-802. PubMed ID: 12788890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas.
    La Rosa S; Uccella S; Dainese L; Marchet S; Placidi C; Vigetti D; Capella C
    Endocr Pathol; 2008; 19(2):104-11. PubMed ID: 18568298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lineage-specific restraint of pituitary gonadotroph cell adenoma growth.
    Chesnokova V; Zonis S; Zhou C; Ben-Shlomo A; Wawrowsky K; Toledano Y; Tong Y; Kovacs K; Scheithauer B; Melmed S
    PLoS One; 2011 Mar; 6(3):e17924. PubMed ID: 21464964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth hormone is a cellular senescence target in pituitary and nonpituitary cells.
    Chesnokova V; Zhou C; Ben-Shlomo A; Zonis S; Tani Y; Ren SG; Melmed S
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3331-9. PubMed ID: 23940366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical studies of chromogranins (A and C) in pituitary adenomas.
    Oda K; Inada K; Osamura RY
    Pathol Res Pract; 1991 Jun; 187(5):626-8. PubMed ID: 1717962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction.
    Evans CO; Young AN; Brown MR; Brat DJ; Parks JS; Neish AS; Oyesiku NM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3097-107. PubMed ID: 11443173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study.
    Tsagarakis S; Kontogeorgos G; Giannou P; Thalassinos N; Woolley J; Besser GM; Grossman A
    Clin Endocrinol (Oxf); 1992 Aug; 37(2):163-7. PubMed ID: 1327588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas.
    Friend KE; Chiou YK; Lopes MB; Laws ER; Hughes KM; Shupnik MA
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1497-504. PubMed ID: 7515390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
    Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor.
    Sun B; Liu X; Yang Y; Dai C; Li Y; Jiao Y; Wei Z; Yao Y; Feng M; Bao X; Deng K; Wang N; Wang R
    J Mol Neurosci; 2016 Jan; 58(1):137-44. PubMed ID: 26676407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
    Hofland LJ; de Herder WW; Waaijers M; Zuijderwijk J; Uitterlinden P; van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3336-43. PubMed ID: 10487708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas.
    Ruebel KH; Jin L; Zhang S; Scheithauer BW; Lloyd RV
    Endocr Pathol; 2001; 12(3):281-9. PubMed ID: 11740049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of activating mutations of CXCR4 in pituitary tumours.
    Lee YH; Noh TW; Lee MK; Jameson JL; Lee EJ
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):209-13. PubMed ID: 19473177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Trans-septo-sphenoidal operation for pituitary adenoma in 92 patients: results and follow-up endocrine studies].
    Gasser RW; Spoendlin H; Finkenstedt G; Pallua AK; Aichner F; Braunsteiner H
    Wien Klin Wochenschr; 1993; 105(7):204-7. PubMed ID: 8385381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
    Lloyd RV; Cano M; Chandler WF; Barkan AL; Horvath E; Kovacs K
    Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.